> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Tandem Diabetes Insulin Algorithm Cleared for Type 2
- URL: https://www.fdaweb.com/tandem-diabetes-insulin-algorithm-cleared-for-type-2/
- Published: 2025-02-25T12:00:00.000Z
- Updated: 2026-09-14T14:53:52.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5158721

FDA has cleared Tandem Diabetes Care’s next-generation automated insulin delivery algorithm, Control-IQ+ technology (Control-IQ+), for use in people with Type 2 diabetes ages 18 and older. The technology was previously 510(k) cleared for use in Type 1 diabetes. The Type 2 version includes enhancements to accommodate input of expanded weight and total daily insulin ranges, the company says.

“Control-IQ powers both Tandem insulin delivery systems – the [t:slim X2](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.tandemdiabetes.com%2Flanding-pages%2Ft-slim-x2%3Futm%5Fsource%3Dgoogle%26utm%5Fmedium%3Dcpc%26utm%5Fcampaign%3DNPD-GGL-BR-Brand-Tier2%26utm%5Fterm%3Dtandem%2520tslim%2520x2%26gad%5Fsource%3D1%26gclid%3DCj0KCQiAy8K8BhCZARIsAKJ8sfRyT8y2uTJ7tsSBPX0GpklpIjRZccYuwPXNIo-Q3M2ckEWLkKz4760aAr75EALw%5FwcB&esheet=54214044&newsitemid=20250225281388&lan=en-US&anchor=t%3Aslim+X2&index=2&md5=681143783b190803878085b557065a0d&ref=fdaweb.com) and [Tandem Mobi](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.tandemdiabetes.com%2Fproducts%2Finsulin-pumps%2Ftandem-mobi&esheet=54214044&newsitemid=20250225281388&lan=en-US&anchor=Tandem+Mobi&index=3&md5=2928babc70ede67cae3c256a8c9da0e1&ref=fdaweb.com) – to provide proven, best-in-class outcomes,” the company says. Recent published data on the technology show immediate and sustained glycemic improvements, including more time in range and improved sleep, it says.